Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study
Nutrients · 2024
DOI: 10.3390/nu16132023 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Evgeny Pokushalov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for New Medical Technologies, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Dietary Supplements, Cholesterol, LDL. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for New Medical Technologies, Novosibirsk, Russia.
Abstract (Originalsprache)
Emerging evidence suggests that personalized dietary supplement regimens can significantly influence lipid metabolism and cardiovascular risk. The efficacy of AI-guided dietary supplement prescriptions, compared with standard physician-guided prescriptions, remains underexplored. In a randomized, parallel-group pilot study, 70 patients aged 40–75 years with LDL-C levels between 70 and 190 mg/dL were enrolled. Participants were randomized to receive either AI-guided dietary supplement prescriptions or standard physician-guided prescriptions for 90 days. The primary endpoint was the percent change in LDL-C levels. Secondary endpoints included changes in total cholesterol, HDL-C, triglycerides, and hsCRP. Supplement adherence and side effects were monitored. Sixty-seven participants completed the study. The AI-guided group experienced a 25.3% reduction in LDL-C levels (95% CI: −28.7% to −21.9%), significantly greater than the 15.2% reduction in the physician-guided group (95% CI: −18.5% to −11.9%; p < 0.01). Total cholesterol decreased by 15.4% (95% CI: −19.1% to −11.7%) in the AI-guided group compared with 8.1% (95% CI: −11.5% to −4.7%) in the physician-guided group (p < 0.05). Triglycerides were reduced by 22.1% (95% CI: −27.2% to −17.0%) in the AI-guided group versus 12.3% (95% CI: −16.7% to −7.9%) in the physician-guided group (p < 0.01). HDL-C and hsCRP changes were not significantly different between groups. The AI-guided group received a broader variety of supplements, including plant sterols, omega-3 fatty acids, red yeast rice, coenzyme Q10, niacin, and fiber supplements. Side effects were minimal and comparable between groups. AI-guided dietary supplement prescriptions significantly reduce LDL-C and triglycerides more effectively than standard physician-guided prescriptions, highlighting the potential for AI-driven personalization in managing hypercholesterolemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for New Medical Technologies, 630090 Novosibirsk, Russia.
- Scientific Research Laboratory, Triangel Scientific, San Francisco, CA 94101, USA.
- Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
ORCID-Profile: Evgeny Pokushalov, Andrey Ponomarenko, Evgenya Shrainer, Dmitry Kudlay
Förderung
- Center for New Medical Technologies, Novosibirsk, Russia
Zitieren
APA
Pokushalov, E., Ponomarenko, A., Smith, J., Johnson, M., Garcia, C., Pak, I., Shrainer, E., Kudlay, D., Bayramova, S., & Miller, R. (2024). Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study. Nutrients. https://doi.org/10.3390/nu16132023
Vancouver
Pokushalov E, Ponomarenko A, Smith J, Johnson M, Garcia C, Pak I, et al. Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study. Nutrients. 2024. doi:10.3390/nu16132023
BibTeX
@article{Pokushalov2024,
author = {Pokushalov, Evgeny and Ponomarenko, Andrey and Smith, John and Johnson, Michael and Garcia, Claire and Pak, Inessa and Shrainer, Evgenya and Kudlay, Dmitry and Bayramova, Sevda and Miller, Richard},
title = {Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16132023}
}
EUVIMED